Back

Severe hypoglycemia: a marker for worse cardiovascular outcomes? a meta-analysis of randomised controlled trials

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Diabetes and the heart Diabetes and the Heart ESC Premium Access ESC Congress 2019

About the speaker

Photo
Assistant Professor Aaqib H Malik

Catholic Medical Center, Manchester (United States of America)

6 More presentations in this session

Presentation thumbnail
Beta-blockers in diabetes with stable coronary heart disease- a cause for concern?
Assistant Professor A. Malik (Manchester, US)
Abstract Slides
Presentation thumbnail
Peripheral neuropathy and diastolic function are associated with adverse cardiovascular outcome in patients with type 1 diabetes mellitus: results from the thousand & 1 study
Doctor M. Jensen (Herlev, DK)
Abstract
Presentation thumbnail
Heterogeneity of treatment effects from an intensive lifestyle weight loss intervention on cardiovascular events in patients with type 2 diabetes: data from the Look AHEAD trial.
Miss T. de Vries (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment
Doctor I. Ikonomidis (Athens, GR)
Abstract
Presentation thumbnail
The ceramide-based Coronary Event Risk Test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes mellitus as well as in those without diabetes
Doctor A. Mader (Feldkirch, AT)
Abstract Slides

Access the full session

Session thumbnail
Diabetes and the heart

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level
thumbnail
Congress Session
Diabetes, obesity, and heart failure
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources